Comment
Serum bilirubin, a potent endogenous antioxidant, has been linked to a number of oxidative stress-mediated diseases including atherosclerosis, cancer, certain rheumatological as well as to neurodegenerative diseases. 1 Additional evidence supporting the inverse association of bilirubin and atherosclerosis has been recently reported by Drs. Perlstein et al. 2 In that study, they retrospectively studied the relationship between serum bilirubin levels and peripheral artery disease (PAD) in more than 7,000 adults from the National Health and Nutrition Examination Survey (NHANES). After adjustment for possible confounding factors, each 0.1 mg/dL increase in serum bilirubin level was found to be associated with 6% reduction in the odds of having PAD. Results of this, so far the largest study of bilirubin and PAD, extends the evidence that bilirubin is a marker for atherosclerosis. The data provided are consistent with other (not discussed) reports showing that increased serum bilirubin levels are associated with a reduced prevalence of PAD. [3] [4] [5] [6] [7] [8] [9] [10] [11] Although Perlstein and colleagues in their paper warn of possible U-shape relationship between serum bilirubin and PAD, this warning is based largely on two previous reports 12, 13 in which inproper 12 or no 13 adjustment for underlying liver disease was performed. When proper adjustment for elevated liver function tests in Breimer et al.´s study 12 was performed, the Ushape relationship disappeared. www.medigraphic.com rum unconjugated bilirubin levels protects from both coronary 15 and peripheral atherosclerotic disease. 8, 10 It should be also noted that elevated aminotransferase activity, a surrogate marker of liver damage, occurs in about 10% of the US population, 16 and is directly related to CHD risk. [17] [18] [19] As a result, elevated aminotransferase activity could be concealing the protective effects of mild isolated hyperbilirubinemia. In this respect it is important to note that the protective effects of bilirubin on PAD in the Perlstein et al.´s study were detected in both individuals with supraphysiological bilirubin concentrations as well as in subsets of individuals that did not have underlying liver disease. 2 Therefore, it appears likely that additional large welldesigned prospective studies that adjust for all possible confounding factors including liver disease will establish that higher levels of serum bilirubin are indeed protective.
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